Home > Journals > Medicine > European Journal of Dermatology > Full text
 
      Advanced search    Shopping cart    French version 
 
Latest books
Catalogue/Search
Collections
All journals
Medicine
European Journal of Dermatology
- Current issue
- Archives
- Subscribe
- Order an issue
- More information
Biology and research
Public health
Agronomy and biotech.
My account
Forgotten password?
Online account   activation
Subscribe
Licences IP
- Instructions for use
- Estimate request form
- Licence agreement
Order an issue
Pay-per-view articles
Newsletters
How can I publish?
Journals
Books
Help for advertisers
Foreign rights
Book sales agents



 

Texte intégral de l'article
 
  Printable version
  Version PDF

Coping with exacerbation in psoriasis and eczema prior to admission in a dermatological ward


European Journal of Dermatology. Volume 16, Number 3, 271-5, May-June 2006, Clinical report


Summary  

Author(s) : AK Wahl, C Mørk, BR Hanestad, S Helland , Department of Public Health and Primary Health Care, University of Bergen, Department of Dermatology, Rikshospitalet University Hospital, Department of Dermatology, Haukeland University Hospital, Norway.

Summary : Chronic dermatologic diseases, such as psoriasis and eczema, may cause significant psycho-social problems and stress. Our objectives were to characterize how hospitalised patients coped with psoriasis and eczema, and to investigate the relationship between coping and quality of life. Data are based on survey forms completed upon admission to the dermatology ward from 212 patients with chronic dermatological diseases, 146 with psoriasis and 66 with eczema. 108 were men, average age 48 years. The Norwegian versions of the standardized survey questionnaires, Jalowiec Coping Scale and Dermatological Life Quality Index, were used to evaluate coping and quality of life. We found that optimism, belief-in-oneself and confrontational coping strategies were most frequently used. Long duration of the disease was correlated to the belief-in-oneself strategy, while short duration was related to supportive strategies. More frequent use of confrontational and optimistic modes was significantly related to better quality of life. More frequent use of emotional and evasive modes was significantly related to poorer quality of life. There was no significant difference between the psoriasis and eczema groups in terms of use of coping strategies, with exception of emotional strategies. Knowledge of coping strategies and quality of life among patients with chronic dermatological diseases is important for improvement in health services for these patients.

Keywords : psoriasis, eczema, coping, quality of life

ARTICLE

Auteur(s) : AK Wahl1,2, C Mørk2, BR Hanestad1, S Helland3

1Department of Public Health and Primary Health Care, University of Bergen
2Department of Dermatology, Rikshospitalet University Hospital
3Department of Dermatology, Haukeland University Hospital, Norway

accepté le 11 Janvier 2006

Chronic dermatological diseases, such as psoriasis and eczema, can make demands on patients which may exhaust their ability to cope and lead to significant social impairment and psychological morbidity. This is especially the case in times of exacerbation of the disease [1-3]. Studies show that psychological factors play an important role in at least 30% of skin diseases. In many cases, the influence of the disease on quality of life is a stronger predictor for psychiatric morbidity than the degree of affection determined by the doctor [4]. One, among other explanations for this, may be found to be related to the individual’s ability to cope and the strategies used.‘Coping’ is commonly regarded as a cognitive and behavioural attempt to deal with, reduce or tolerate external and/or internal demands that are experienced as being beyond the person’s resources [5].Coping is thereby linked to the use of different strategies and is an important mediating factor in terms of how the person adapts to the realities of the illness. It is not clear, however, which of the coping strategies or modes used to cope are the most effective. What is good and bad must be seen in the light of the situation in which problems occur [5].There have been few studies carried out in relation to coping by patients with chronic skin diseases. Most of the studies performed have evaluated coping with chronic dermatological diseases in general without focusing on specifically stressing clinical settings, such as exacerbation of disease symptoms. It has previously been reported that strategies of the optimistic and control type were most often used to deal with stress and problems related to daily living and functioning with psoriasis [6]. Studies have shown that people with psoriasis using emotional coping reported greater disability, poorer mental health and quality of life [7].However, to our knowledge, no studies have evaluated and compared coping during exacerbation of the disease in the period prior to admission to the dermatology ward in persons with psoriasis and chronic eczema. The purpose of this article is to look further into this matter. We attempt to answer the following questions:
  • Which coping strategies are used before admission to the dermatology ward?
  • Are there differences in the use of coping strategies between the various diagnosed groups?
  • Are there differences in the use of coping strategies between the sexes?
  • What relationship is there between age and duration of illness and the use of coping strategies?
  • What relationship is there between the use of coping strategies and the experience of difficulties linked to living and functioning with the skin disease?
  • Is there a relationship between coping strategy and quality of life?

Material and methods

Design

Data were gathered with a survey form filled in upon admission to the dermatology ward.

Subjects

The present paper is based on subjects with psoriasis and chronic eczema who were admitted over a period of one year to the dermatology ward at the five Norwegian regional hospitals with dermatological departments. The patients concerned were chosen and asked to participate by the nurse heading the project, and doctors responsible for the patients. All included patients gave written informed consent. The study was authorized by the Norwegian Social Science Data Archives and the Regional Committee for Medical Ethics – region II provided ethical approval for the study.

Instruments

Coping

The Jalowiec Coping Scale (JCS) was applied to measure the use of coping strategies. This questionnaire contains 60 different coping strategies that are combined under the following eight different categories: confrontational (tried to change the situation), evasive (put off facing up to the problem), optimistic (tried to think positively), fatalistic (accepted the situation because very little could be done), emotional (worried about the problem), palliative (tried to keep busy and work harder), supportive (depended on others to help you out) and belief-in-oneself (preferred to work things out yourself).

The patients were asked about the coping strategies they used to face their disease during the last weeks before admission in a dermatology ward, and to determine and indicate how much they used each coping strategy in terms of skin disease-related problems on a scale rating from 0-3, where 0 indicates non-use and 3 frequent use [8]. In this study, it was decided to use relative scores to illustrate the use of coping, i.e. the average score for each coping category is divided by the average score for all of the categories. Relative scores have the advantage that they compensate for discrepancies in numbers of questions in each scale as well as for individual differences in responses. Relative scores, therefore, indicate how much of a person’s coping can be related to the individual coping category. JCS has been translated into Norwegian and has been previously used in Norwegian psoriasis patients [6, 7].

Quality of life

Quality of life is measured by aid of the Norwegian version of the Dermatologic Life Quality Index (DLQI-N) [9]. The form was originally developed by Finlay and is now used internationally in many studies [10]. DLQI-N comprises ten questions that concern dermatologic symptoms, one’s personal perceptions of the skin, restriction of skin afflictions and treatment in order to function daily. Alternative responses that may be chosen for each individual question span from 0 (not at all) to 3 (significantly) and these are added together to yield a total score (0-30), wherein the higher values indicate poorer quality of life.

The perception of living with the disease

This was assessed by posing a single-item question about whether the patients find it difficult to live with psoriasis or eczema. The question contains six alternative responses (1. Yes, I feel it is a burden; 2. Yes, I think about it a lot; 3. Yes, sometimes; 4. No, rarely; 5. No, I hardly ever think about it; and 6. I feel exactly the same as people who do not suffer from psoriasis or eczema).

Socio-demographic and clinical variables

Socio-demographic (questions on patient background, such as age, sex, civil status and education, work), and clinical data were recorded.

Statistical analysis

SPSS version 11 is used as an analysis programme in this study. Descriptive data are used to describe the use of coping strategies. In terms of the differences and relationships between socio-demographic factors, disease groups and perception of difficulties resulting from the disease, as well as coping, cross tabs with chi square, independent t-test, one-way ANOVA and correlation (Pearson’s r) analyses were used. Correlation analysis (Pearson’s r) was used to examine the relationship between various coping strategies and quality of life, and the perception of living with the disease.

Results

Participants’ characteristics

In total 212 patients with a dermatologist-confirmed diagnosis of psoriasis (n = 146) and chronic eczema (n = 66) (108 men and 104 women; mean ± SD age 48 ± 16.7 years) were recruited to the study. 47% were married and 80% of the respondents had an education level up to and including secondary school. 43% report not been admitted to the dermatology ward within the past two years, while 23% have been admitted once, and 18% twice. For further information about the different disease groups, see (Table 1). There were no statistical significant differences between the disease groups with regard to background variables, except for age. The eczema group was younger than the psoriasis group (p = 0.023).
Table 1 Characteristics of the psoriasis and the eczema samples

Psoriasis (n = 146)

Eczema (n = 66)

P values for differences

Gender (n)

Male

69

38

.178

Female

76

28

Age mean (SD) years

49.5 (15.6)

43.8 (18.2)

.023

Education

Primary school

57

16

.225

Secondary school

60

34

University /college < 4 years

19

9

University/college > 4 years

8

5

Marital status

Married

70

28

.770

Not married

4

23

Divorced

22

9

Widowed

10

3

Length of disorder mean (SD) years

19.1 (14.3)

22.0 (15.9)

.200

Number of admissions during the last two years mean (SD)

1.3 (1.7)

1.3 (1.4)

.844

Use of coping strategies

The results indicate that the optimistic, belief-in-oneself and confrontational strategies are most frequently used among patients who are admitted to the dermatology ward for treatment of chronic dermatologic diseases. The coping strategies used least are of the emotional and fatalistic type (Table 2).
Table 2 Use of coping strategies, quality of life and perception of living with disease (mean, SD, and p values for differences between groups)

Psoriasis

Eczema

Mean (SD)

Mean (SD)

P values for differences

Coping strategies

Confrontational

0.14 (0.04)

0.13 (0.03)

.37

Evasive

0.13 (0.03)

0.12 (0.03)

.30

Optimistic

0.18 (0.04)

0.18 (0.12)

.89

Fatalistic

0.11 (0.05)

0.10 (0.04)

.37

Palliative

0.10 (0.03)

0.11 (0.03)

.87

Supportive

0.11 (0.04)

0.10 (0.04)

.79

Belief-in-oneself

0.15 (0.03)

0.15 (0.03)

.81

Emotional

0.08 (0.04)

0.10 (0.04)

.02

Quality of Life

19.2 (7.3)

19.9 (5.9)

.56

Perception of living with disease

1.8 (1.2)

1.7 (1.0)

.37

Differences in use of coping strategies

On examining the differences between the diagnosed groups we show that the eczema group used the emotional coping strategy significantly more often than the psoriasis group (p < 0.05). There was no significant difference between the groups in terms of use of the other coping modes. The results also indicate significant differences between the sexes and age in relation to the use of emotional coping strategies. Women use this type of strategy significantly more often than men do (p < 0.01). Younger people also use emotional coping more often than older people (r = – .23: p < 0.01). Duration of illness is significantly related to supportive coping strategy and belief-in-oneself coping strategies. The longer one has had the disease, the more often one uses the belief-in-oneself mode (r = .26: p < 0.01). The opposite relationship is seen in terms of supportive coping strategies. The shorter the length of illness, the more often supportive strategies are used (r = – .25; p < 0.01). Number of admissions shows only a statistical significant positive correlation with the palliative coping strategy (r = .18: p < 0.05). Lastly, level of education shows a statistically significant positive correlation with the confrontational coping strategy (r = .21: p < 0.01).

Relations between coping and quality of life and the perception of living with the disease

Analyses indicate that several of the coping strategies are related to quality of life and the perception of living with the disease (Table 3).

Those who more often use confrontational (r = – .20: p < 0.05) and optimistic (r = – .30: p < 0.001) modes report significantly better quality of life. More frequent use of evasive (r = .18: p < 0.05) and emotional (r = .39: p < 0.001) modes is related to poorer quality of life.

The same pattern is seen with regard to the relationship between coping strategies and the perception of living with the disease. Concerning the relationship between perception of how difficult it is to live and function with a dermatologic disease and the use of coping, it is indicated that those who perceive a higher degree of difficulty in terms of living and functioning with a dermatologic disease also use fatalistic (r = –.16: p < 0.05) and emotional (r = – .28: p < 0.001) coping strategies significantly more often. Those who feel that it is easier to live and function with a dermatologic disease use confrontational (r = .26: p < 0.01) and optimistic (r = .16: p < 0.05) coping strategies significantly more often.
Table 3 Correlation analysis (Pearson’s r) between coping, quality of life and the perception of living with disease

Quality of Life

Perception of living with disease

Coping strategies

Confrontational

– .20*

.26**

Evasive

.18*

– .14

Optimistic

– .30***

.16*

Fatalistic

.04

– .16*

Palliative

.10

.01

Supportive

.02

.01

Belief-in-oneself

.16

– .00

Emotional

.39***

– .28***

Discussion

This study has focused on how persons with chronic dermatologic diseases who are admitted to the dermatology ward cope with an exacerbation of the disease. The results indicate that optimistic, confrontational and belief-in-oneself strategies are most often used in the period prior to admission. Furthermore, it is indicated that emotional strategies are used more by patients with eczema and by women. Similar findings are reported in other studies. In a study of 250 patients with psoriasis it was found that acceptation, planning, active coping and positive thinking were most often used. Use of alcohol, religion and repression were least used. This study also showed great similarities in the use of coping strategies between different diseases. When compared with normal controls, patients with psoriasis as a whole tended to use significantly less active coping strategies, planning, positive reinterpretation and humour. There were marked similarities between the frequency of use of particular coping strategies in patients with psoriasis and patients with other medical conditions [11]. It appears that illness brings with it a generic form of coping that may require shaping to fit the individual demands of diseases such as psoriasis.

Another finding in our study is that long illness duration is related to the more frequent use of strategies of the type belief-in-oneself and less frequent use of supportive strategies. We have not found studies that report similar findings related to chronic dermatological diseases. The fact that people who have lived and functioned longer with the disease, more often trust their own evaluation of the situation and use fewer supportive strategies, may be explained by their having established individual knowledge concerning the illness, thereby making them less dependent on support from others to cope with problems related to the disease.

The results of our study also indicate that the perception of it being difficult to live and function with a chronic dermatological disease is related to a more frequent use of emotional strategies. Use of confrontational strategies is related to better quality of life and the notion that the illness is easier to live with. Coping is regarded as an important mediating factor in terms of adapting to the illness. Concerning chronic illness, several studies show that more use of active, expressive and optimistic strategies is related to improved ability to function and better psychological well-being [12].

Wahl et al. [7] found that patients with psoriasis who used emotional coping strategies reported more disability, poorer mental health and worse overall quality of life. Furthermore, patients who more frequently used normalising/optimistic coping reported higher levels of mental health. Rapp et al. [13] found in a study of 318 individuals with psoriasis that commonly used coping strategies such as telling others about psoriasis, covering the lesions and avoiding people were associated with greater decrements in health related quality of life after controlling for covariates. How patients cope with the social aspects of psoriasis is associated with their quality of life. In a longitudinal study of 69 patients with psoriasis it was found that that a strong illness identity was associated with more visits to the outpatient clinic, and worse outcome on physical health, social functioning, mental health, health perceptions and depression. Strong beliefs that the disease is controllable/curable and that the disease has disabling consequences were also related to more clinic visits and more negatively perceived health, respectively. Patients who initially engaged in coping characterized by more expression of emotions, seeking more social support, seeking more distraction, and less passive coping were prescribed a lower number of different therapies, were less anxious, less depressed, and had a better physical health 1 year later [14].

It is important to have knowledge concerning the use of coping strategies and quality of life among patients with chronic dermatological diseases, such as psoriasis and eczema, in order to integrate psychological interventions and coping techniques into standard care protocols. Results from a recently published study by Fortune et al. [15] suggest that while clearance of psoriasis produces a significant reduction in factors specific to psoriasis (disability and stress), it does not impact upon psychological distress, on patients’ beliefs about psoriasis or on coping. This observation highlights the complex features of patients’ psychological experience of psoriasis and may provide further impetus for integration of psychological interventions into standard care protocols.

Conclusion

The present study found that optimistic, belief-in-oneself and confrontational coping strategies are most frequently used by subjects with psoriasis and chronic eczema in the period prior to admission to a dermatological ward. We also found that longer duration of the disease is related to more frequent use of belief-in-oneself strategies, while shorter duration is related to more frequent use of more supportive strategies. Furthermore, more frequent use of confrontational and optimistic modes is significantly related to better quality of life. More frequent use of emotional and evasive modes is significantly related to poorer quality of life. In general, as for other studies within this field, our findings highlight the need for integrating psychological interventions into standard care protocols.

References

1 Zachariae R, Zachariae H, Blomqvist K, Davidsson S, Molin L, Mork C, Sigurgeirsson B. Self-reported stress reactivity and psoriasis-related stress of Nordic psoriasis sufferers. J Eur Acad Dermatol Venereol 2004; 18: 27-36.

2 Zachariae R, Zachariae C, Ibsen HH, Mortensen JT, Wulf HC. Psychological symptoms and quality of life of dermatology outpatients and hospitalized dermatology patients. Acta Derm Venereol 2004; 84: 205-12.

3 Wahl AK, Gjengedal E, Hanestad BR. The bodily suffering of living with severe psoriasis: in-depth interviews with 22 hospitalized patients with psoriasis. Qual Health Res 2002; 12: 250-61.

4 Gupta MA, Gupta AK. Psychiatric and psychological co-morbidity in patients with dermatologic disorders: epidemiology and management. Am J Clin Dermatol 2003; 4: 833-42.

5 Lazarus RS, Folkman S. Stress, appraisal, and coping. New York: Springer Publ. Co, 1984; (xiii, 445 s).

6 Wahl A, Moum T, Hanestad BR, Wiklund I, Kalfoss MH. Adapting the Jalowiec Coping Scale in Norwegian adult psoriasis patients. Qual Life Res 1999; 8: 435-45.

7 Wahl A, Hanestad BR, Wiklund I, Moum T. Coping and quality of life in patients with psoriasis. Qual Life Res 1999; 8: 427-33.

8 Jalowiec A. The Jalowiec coping Sclale. In: Strickland OL, Dilorio C, eds. Measurement of Nursing outcomes. 2nd Edition, Vol. 3. Springer Publ. Co, 2003.

9 Mork C, Wahl A, Moum T. The Norwegian version of the dermatology life quality index: a study of validity and reliability in psoriatics. Acta Derm Venereol 2002; 82: 347-51.

10 Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)–a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210-6.

11 Fortune DG, Richards HL, Main CJ, Griffiths CE. Patients’ strategies for coping with psoriasis. Clin Exp Dermatol 2002; 27: 177-84.

12 Miller JF. Coping with chronic illness: overcoming powerlessness. 3rd ed. Philadelphia: F.A. Davis, 2000; (XIV, 573 s).

13 Rapp SR, Cottrell CA, Leary MA. Social coping strategies associated with quality of life decrements among psoriasis patients. Br J Dermatol 2001; 145: 610-6.

14 Scharloo M, Kaptein AA, Weinman J, Bergman W, Vermeer BJ, Rooijmans HG. Patients’ illness perceptions and coping as predictors of functional status in psoriasis: a 1-year follow-up. Br J Dermatol 2000; 142: 899-907.

15 Fortune DG, Richards HL, Kirby B, McElhone K, Main CJ, Griffiths CE. Successful treatment of psoriasis improves psoriasis-specific but not more general aspects of patients’ well-being. Br J Dermatol 2004; 151: 1219-26.


 

About us - Contact us - Conditions of use - Secure payment
Latest news - Conferences
Copyright © 2007 John Libbey Eurotext - All rights reserved
[ Legal information - Powered by Dolomède ]